ArticleJournal of clinical medicine2023

The Efficacy and Safety of Rituximab in Patients with Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease: Case Series.

Youngeun Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.